1. Methicillin-resistant Staphylococcus aureus (MRSA)Current/Emerging Resistant Bacteria Infection Types Resistance Notes Methicillin-resistant Staphylococcus aureus“staph” (MRSA) Infections can range from skin and soft tissue infections (cellulitis, abscess), to urinary tract infections, osteomyelitis (bone...
The cell envelope of Gram-negative bacteria belonging to the Burkholderia cepacia complex (Bcc) presents unique restrictions to antibiotic penetration. As a consequence, Bcc species are notorious for causing recalcitrant multidrug-resistant infections in
Antibiotic-resistant infections in the critically ill adult[J] . Fernanda Silveira,Shigeki Fujitani,David L Paterson.Clinics in Laboratory Medicine . 2004 (2)Silveira F, Fujitani S, Paterson DL. Antibiotic-resistant infec- tions in the critically ill adult [ J ]. Clin Lab Med,2004,24 (2) ...
Gram-negative bacteria are responsible for an increasing number of deaths caused by antibiotic-resistant infections1,2. The bacterial natural product colistin is considered the last line of defence against a number of Gram-negative pathogens. The recent global spread of the plasmid-borne mobilized col...
Introduction Antibiotic-resistant infections affect 2 million people and are associated with 23 000 deaths annually in the United States, according to the Centers for Disease Control and Prevention (CDC).1 Antibiotic use is the primary driver of antibiotic resistance1 and leads to adverse events ...
is poorly absorbed from the gastrointestinal tract and is usually given by intravenous injection. It is used for the treatment of serious staphylococcal infections caused by strains resistant to the various penicillins. Its use against MRSA led to the emergence of vancomycin-resistantStaphylococcus aureu...
Roghmann MC, McGrail L (2006) Novel ways of preventing antibiotic-resistant infections: what might the future hold? Am J InfectControl 34:469–475 Google Scholar Rosander A, Connolly E, Roos S (2008) Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730...
While new antimicrobials from classical in vitro research might help us fight antibiotic-resistant infections, they are likely to be as ineffective against antibiotic persistence in vivo as the regular antibiotic drugs that are currently available. One promising alternative strategy to combat antibiotic ...
(1606–1613, a 0.44% increase). However, we found two previously unknown antibiotic-resistant relationships (surA, CRA, Vancomycin) and (asmA, CRA, Vancomycin) only after reinstating the resolved inconsistencies into the knowledge graph, something that demonstrates the importance of inconsistency ...
Within the United States, it is estimated that 2.8 million antibiotic-resistant infections and 35,000 deaths occur yearly.1 Although new antimicrobial therapies continue to be investigated, the novel drug treatment pipeline is extremely limited, and the number of therapies under investigation remains ...